Diabetes Drug Recalled Due to Cancer-Causing Agents

metformin drug recall

Metformin, a widely-used diabetes drug, was recalled after manufacturers found it contained high levels of N-nitrosodimethylamine (NDMA), an ingredient that can cause cancer. Metformin is used to treat several type 2 diabetes symptoms and has been recalled by numerous drug companies.

Metformin tablets are used to treat type 2 diabetes and are designed to lower glucose levels. The prevalence of diabetes has gradually increased over the past ten years, and this drug has been widely used by patients with diabetes due to its low cost.

Metformin Recall

The Food and Drug Administration (FDA) is still investigating where NDMA comes from and how it ended up in Metformin products. Officials currently do not know how long NDMA has been in metformin or the exact risk for patients who have taken or are currently taking this medication.

The original recall began after the drug was found to contain dangerous levels of nitrosodimethylamine, which can cause cancer, according to the FDA. The pills, which are manufactured by manufacturer Marksans Pharma Ltd, of Mumbai, India, are sold in the United States through Time-Cap Labs Inc., located on Long Island in Farmingdale.

It should be noted that, even if your Metformin has been recalled, you should continue taking it until you are given a replacement subscription or treatment option by your doctor or pharmacist. The danger of stopping treatment without another treatment plan in place is likely more immediately hazardous for type 2 diabetes patients than the risk of cancer.

Nitrosodimethylamine Dangers 

NDMA contamination can occur when certain drugs are stored at room temperature for prolonged periods of time. This same compound can also be found in cured meats and even drinking water. If continually ingested over time, it could lead to an increased risk of cancer. 

There has been extensive research into the effects that this can have on the human body, and current research shows an alarming connection between cancer and NDMA.

What to Do If You’ve Bought or Sold Metformin

All manufacturers of Metformin should evaluate the risk of excessive NDMA in their drugs and thoroughly test any at-risk products. If any testing shows high levels of NDMA which are above the recommended intake, manufacturers should cease distribution and issue an immediate recall.

If you are currency taking Metformin as part of your prescription for type 2 diabetes, you should talk with your doctor or pharmacist as soon as possible to evaluate your options, but continue taking the medication until you receive an option or prescription for alternative care.

It is advised that you contact their physician or healthcare provider if you experience or have experienced any problems related to the intake or use of this medication. You can also return their unused Metformin to their local pharmacy or doctor.

Medications are expected to meet certain standards, and manufacturers and pharmacists are required to make patients aware of side effects and possible risks of using those medications. 

Because Metformin users were not made aware of its potentially carcinogenic effects, you may have grounds for a pharmaceutical litigation claim if you have taken Metformin and developed cancer. If you wish to pursue legal action, a pharmaceutical litigation lawyer can help evaluate and build your case.